Concerns on Bebtelovimab (LY‐CoV1404) used to neutralize Omicron subvariants.

MLA

Wang, Xuejun, et al. “Concerns on Bebtelovimab (LY‐CoV1404) Used to Neutralize Omicron Subvariants.” Journal of Medical Virology, vol. 95, no. 2, Feb. 2023, pp. 1–3. EBSCOhost, https://doi.org/10.1002/jmv.28565.

APA

Wang, X., Yang, Y., Song, Z., Wang, Y., Yang, P., Li, X., Wang, F., Wang, M., Shao, L., & Wang, S. (2023). Concerns on Bebtelovimab (LY‐CoV1404) used to neutralize Omicron subvariants. Journal of Medical Virology, 95(2), 1–3. https://doi.org/10.1002/jmv.28565

Chicago

Wang, Xuejun, Yang Yang, Zhifei Song, Yiming Wang, Peng Yang, Xinyu Li, Fei Wang, Mingming Wang, Liting Shao, and Shengqi Wang. 2023. “Concerns on Bebtelovimab (LY‐CoV1404) Used to Neutralize Omicron Subvariants.” Journal of Medical Virology 95 (2): 1–3. doi:10.1002/jmv.28565.